Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Clinical Trial1
- Clinical Study1
- Comparative Study1
- Controlled Clinical Trial1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- J Int Med Res1
Search Results
Sort by
- BookMark Kaplan and Mason Donovan.Summary: In today's increasingly diverse, global, interconnected business world, diversity and inclusion (D & I) is no longer just "the right thing to do," it is a core leadership competency and central to the success of business. Working effectively across differences such as gender, culture, generational, race, and sexual orientation not only leads to a more productive, innovative corporate culture, but also to a better engagement with customers and clients. The Inclusion Dividend provides a framework to tap the bottom line impact that results from an inclusive culture. Most leaders have the intent to be inclusive, however translating that intent into a truly inclusive outcome with employees, customers, and other stakeholders requires a focused change effort. The authors explain that challenge and provide straightforward advice on how to achieve the kind of meritocracy that will result in a tangible dividend and move companies ahead of their competition. An enhanced eBook version with video and audio, optimized for color tablets, is also available.
Contents:
Diversity? Inclusion? What do we mean?
The business case for inclusion
Understanding key D & I concepts
Framing a sustainable inclusion initiative
Unconscious and unintentional bias
Insider-outsider dynamics
Dimensions of difference
Critical leadership competencies
Change strategies for creating inclusion.Digital Access ProQuest Ebook Central 2013Limited to 3 simultaneous users - ArticleFava G, Galli L, Pollini C, Liverta C, Vicari A, Pontiroli AE.J Int Med Res. 1977;5(5):301-7.In a double-blind trial carried out on 60 patients with osteoarthritis at various localizations, ketoprofen (Orudis), administered as a single nightly 100 mg suppository for ten days, was significantly more active and better tolerated than indomethacin, administered in the same way. Patient's and doctor's assessment was also in favour of Orudis. Laboratory examinations were not affected by either drug.